DTP Bid Led by Imperial College London

Imperial College London will lead a consortium to train the next generation of biomedical researchers through a Doctoral Training Partnership funded by the Medical Research Council. This matters because the UK needs a steady pipeline of skilled scientists to tackle complex health challenges, from antimicrobial resistance to dementia. The current system of postgraduate training must adapt to keep pace with rapidly evolving research methods and technologies. Without coordinated investment in training, the country risks falling behind in its ability to conduct world-class medical research. The partnership will provide structured PhD programmes that combine hands-on laboratory work with training in data analysis, public engagement, and translation of discoveries into clinical practice. If successful, this approach could produce researchers better equipped to turn fundamental biological insights into new diagnostics, treatments, and preventive strategies. The impact will be felt not in immediate products but in the quality of people entering the research workforce—the same people who may later develop vaccines, improve medical imaging, or uncover mechanisms of disease. This is primarily an investment in skills and capacity rather than a specific research project. The long-term payoff depends on where those trained scientists apply their expertise.